| Christine Omerhi Pincince, RN | |
|
1 River St, Wakefield, RI 02879-3214 | |
| (401) 783-5646 | |
| (401) 651-7576 |
| Full Name | Christine Omerhi Pincince |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 1 River St, Wakefield, Rhode Island |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134638000 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WS0200X | Registered Nurse - School | RN52251 (Rhode Island) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | APRN01773 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Miriam Hospital | Providence, RI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Thundermist Health Center | 1557270477 | 131 |
News Archive
Tissue engineering has a unique set of tools and technologies for developing preventive strategies, diagnostics, and treatments that can play an important role during the ongoing COVID-19 pandemic.
PerFluoroAlkyl Substances (PFASs) and precursor compounds have been used in a wide variety of commercial and industrial products over the past six decades. Applications include water and oil repellent coatings, e.g. for textiles, paper products, carpets and food packaging, pharmaceuticals and surfactants in cleaning products and fire-fighting foams.
Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19).
Millions of low-income people could be required to pay more for health care under a proposed federal policy that would give states more freedom to impose co-payments and other charges on Medicaid patients.
Findings from a 24-week Phase 3 clinical study published online in the latest issue of Diabetes Care demonstrated that the investigational drug dapagliflozin, administered as a monotherapy, achieved statistically significant mean reductions at 5 mg and 10 mg doses once daily in the primary endpoint of glycosylated hemoglobin levels (HbA1c) in treatment-naïve adult patients with newly diagnosed type 2 diabetes, compared to placebo.
› Verified 3 days ago
| Entity Name | Thundermist Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700041001 PECOS PAC ID: 1557270477 Enrollment ID: O20040211000909 |
News Archive
Tissue engineering has a unique set of tools and technologies for developing preventive strategies, diagnostics, and treatments that can play an important role during the ongoing COVID-19 pandemic.
PerFluoroAlkyl Substances (PFASs) and precursor compounds have been used in a wide variety of commercial and industrial products over the past six decades. Applications include water and oil repellent coatings, e.g. for textiles, paper products, carpets and food packaging, pharmaceuticals and surfactants in cleaning products and fire-fighting foams.
Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19).
Millions of low-income people could be required to pay more for health care under a proposed federal policy that would give states more freedom to impose co-payments and other charges on Medicaid patients.
Findings from a 24-week Phase 3 clinical study published online in the latest issue of Diabetes Care demonstrated that the investigational drug dapagliflozin, administered as a monotherapy, achieved statistically significant mean reductions at 5 mg and 10 mg doses once daily in the primary endpoint of glycosylated hemoglobin levels (HbA1c) in treatment-naïve adult patients with newly diagnosed type 2 diabetes, compared to placebo.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Christine Omerhi Pincince, RN 1 River St, Wakefield, RI 02879-3214 Ph: (401) 783-0523 | Christine Omerhi Pincince, RN 1 River St, Wakefield, RI 02879-3214 Ph: (401) 783-5646 |
News Archive
Tissue engineering has a unique set of tools and technologies for developing preventive strategies, diagnostics, and treatments that can play an important role during the ongoing COVID-19 pandemic.
PerFluoroAlkyl Substances (PFASs) and precursor compounds have been used in a wide variety of commercial and industrial products over the past six decades. Applications include water and oil repellent coatings, e.g. for textiles, paper products, carpets and food packaging, pharmaceuticals and surfactants in cleaning products and fire-fighting foams.
Researchers in the UK have developed a protein-based subunit vaccine directed against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could serve as an alternative to the mRNA-based vaccines currently approved for protecting against coronavirus disease 2019 (COVID-19).
Millions of low-income people could be required to pay more for health care under a proposed federal policy that would give states more freedom to impose co-payments and other charges on Medicaid patients.
Findings from a 24-week Phase 3 clinical study published online in the latest issue of Diabetes Care demonstrated that the investigational drug dapagliflozin, administered as a monotherapy, achieved statistically significant mean reductions at 5 mg and 10 mg doses once daily in the primary endpoint of glycosylated hemoglobin levels (HbA1c) in treatment-naïve adult patients with newly diagnosed type 2 diabetes, compared to placebo.
› Verified 3 days ago
Laura Davidson, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1 River St, Wakefield, RI 02879 Phone: 401-783-5646 Fax: 401-783-9448 | |
Diane Mckeeff, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 Cherry Ln, Suite 1b, Wakefield, RI 02879 Phone: 401-789-7137 Fax: 401-685-0420 | |
Mr. Robert Desrosiers, APRN NP-C Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 11 Main St, Store # 2065, Wakefield, RI 02879 Phone: 401-783-3384 | |
Mrs. Mollie Jean Garrison, AG-ACNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Kenyon Ave, Wakefield, RI 02879 Phone: 401-782-8000 | |
Caroline H. Jenckes, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 100 Kenyon Ave, Wakefield, RI 02879 Phone: 401-788-1590 | |
Ms. Jill Susan Iacono, APRN FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 55 Cherry Ln Ste 1b, Wakefield, RI 02879 Phone: 401-284-4555 | |
Lauren Houle, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 70 Kenyon Ave Unit 322, Wakefield, RI 02879 Phone: 401-783-1896 |